Related Experiment Video
Updated: May 23, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Carnitine supplementation improves cardiac strain rate in children on chronic hemodialysis
Kristen Sgambat1, Lowell Frank, Ahmad Ellini
1Department of Nephrology, Children's National Medical Center, 111 Michigan Ave NW, Washington, DC 20010, USA. ksgambat@childrensnational.org
Background:
Carnitine plays a key role in energy production in the myocardium. Carnitine deficiency commonly occurs in patients on chronic hemodialysis (HD) and may contribute to cardiomyopathy.
Methods:
Carnitine levels and cardiac function of nine children on HD were assessed before and after 6 months of intravenous levocarnitine supplementation. Standard echocardiographic (ECHO) measures of left ventricular (LV) function as well as strain and strain rate analysis using novel speckle-tracking echocardiography were performed and the results compared to those of a control group of children on chronic HD.
Results:
Following carnitine supplementation, total (49.0 ± 1.67 vs. 298.0 ± 31.8 μmol/L) and free carnitine (29.0 ± 1.20 vs. 180.4 ± 19.2 μmol/L) increased (p < 0.0001), and the acyl:free (A:F) carnitine ratio improved (0.73 ± 0.04 vs. 0.65 ± 0.05; p = 0.02). There were no changes in standard ECHO measures of LV function, including end diastolic dimension, mass index, ejection fraction, and fractional shortening. There was significant (p = 0.017) improvement in the longitudinal strain rate (-1.48 ± 0.11 vs -1.91 ± 0.12) after carnitine supplementation in the study group. No improvements in LV function, strain, or strain rate occurred in controls.
Conclusions:
Levocarnitine supplementation improved carnitine levels, the A:F ratio, and longitudinal strain rate in children on HD.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Hemodialysis II: Procedure and Complications
Cardiomyopathy II: Dilated Cardiomyopathy
Hemodialysis III: Nursing Management
Continuous Renal Replacement Therapy